SCHEMBL23019192

SCHEMBL23019192

NC1CC2CN(C(=O)CC3CC3)CC2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.45
KDM1A O60341 3/20 0.42
SMYD3 Q9H7B4 1/20 0.39
CHRNB2 P17787 3/20 0.35
CHRNA3 P32297 3/20 0.35
CHRNA4 P43681 3/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNB3 Q05901 2/20 0.35
CHRNA6 Q15825 2/20 0.35
AURKA O14965 1/20 0.34
JAK1 P23458 1/20 0.34
CYP1A2 P05177 1/20 0.34
CHRM4 P08173 1/20 0.34
NR1H2 P55055 1/20 0.33
TPSAB1 Q15661 1/20 0.33
TPSD1 Q9BZJ3 1/20 0.33
TPSG1 Q9NRR2 1/20 0.33
DPP4 P27487 2/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25307104 0.86 KDM1A (0.45) NAMPTKDM1ASMYD3CHRNB2CHRNA3
Hydrochloric Acid SCHEMBL25300129 0.84 KDM1A (0.44) NAMPTKDM1ASMYD3CHRNB2CHRNA3
SCHEMBL26256040 0.78 NAMPT (0.39) NAMPTKDM1ASMYD3CHRNB2CHRNA3
SCHEMBL14211316 0.74 CHRNB2 (0.60) NAMPTCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL1462662 0.74 CHRNB2 (0.63) NAMPTSMYD3CHRNB2CHRNA3CHRNA4
SCHEMBL20082804 0.74 JAK1 (0.43) JAK1DPP4
SCHEMBL1514801 0.73 GABRR1 (0.33) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL5649631 0.73 GABRR1 (0.33) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL20580436 0.73 GABRR1 (0.33) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL8509880 0.73 GABRR1 (0.33) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3347097-B1 SUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF THE KINASES JAK, FLT3 AND AURORA SUNSHINE LAKE PHARMA CO LTD (CN) 2021-02-24 EP disclosed